This site is intended for Healthcare Professionals only.

New product name, same powerful anti-inflammatory pain relief

Date:

Share post:

Voltarol Gel has introduced product name changes to help patients and pharmacy professionals find the appropriate product for their needs. The formulations have stayed the same.

Voltarol 12 Hour Joint Pain Relief 2.32% Gel is now called Voltarol Max Strength Pain Relief 2.32% Gel and is available as a pharmacy pack. The 100g pack contains an easy open flip top cap. The formulation is also available in smaller pack sizes for the GSL fixture as Voltarol Joint & Back Pain Relief 2.32% Gel.

Voltarol Max Strength Pain Relief Gel contains diclofenac, a potent NSAID. The topical gel targets the inflamed area to relieve pain at its source instead of masking it. Voltarol relieves pain, reduces inflammation, and speeds recovery. The 2% strength gel offers the convenience of all-day pain relief for joints, muscles, sprains and strains, when applied twice daily.

You can find out more about the Voltarol range and access pharmacy education resources at this website.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

[my_vc_php_output]

Related articles

Boots pharmacy closures in Hampton leave vulnerable residents struggling – Munira Wilson MP tells Parliament

She pointed out that a major factor driving pharmacy closures is a significant real-term reduction in pharmacy funding   Munira Wilson,...

Prof Mahendra Patel leads innovative research study: Community pharmacies to address health disparities

The research study is set to utilise community pharmacies and pharmacy technicians to recruit participants and gather crucial...

Rosehill Pharmacy gets a makeover under new leadership

Rosehill Pharmacy in Sutton has recently undergone a significant transformation with its acquisition by Arun Kanagaratnam, who took...

Drug shortage: Kay-Cee-L syrup to be out of stock from late September

Healthcare providers are advised to prioritise remaining supplies of Kay-Cee-L syrup for patients requiring doses of less than...